Passage Bio Inc. is a clinical-stage genetic medicines company focused on developing one-time gene therapies for neurodegenerative diseases. Its current programs target rare, monogenic disorders of the central nervous system, with lead efforts centered on elevating progranulin levels and addressing underlying disease biology. The company’s pipeline includes clinical and early-stage candidates for conditions such as frontotemporal dementia, GM1 gangliosidosis, Krabbe disease, and other severe neurological disorders with limited treatment options. Passage Bio Inc. works in gene delivery and translational research to advance therapies designed for precise genetic correction or replacement within the brain and nervous system. Headquartered in Philadelphia, Pennsylvania, the company operates as a focused biotechnology developer within the genetic medicines field.
WebsiteOne Commerce Square
Philadelphia, PA, 19103
United States
Investors talking about PASG also mention
| # | Name | Attention |
|---|---|---|
| 1 | JKL - iShares Morningstar Small-Cap Value ETF | —— |
| 2 | AtomOneATONE | 0%+0 |
| 3 | Galecto Inc.GLTO | 0%0 |
| 4 | Akash NetworkAKT | 0.01%-0.01 |
| 5 | Atomera IncATOM | 0%+0 |
| 6 | OsmosisOSMO | 0%+0 |
| 7 | NGM - NGM Biopharmaceuticals, Inc. | —— |
| 8 | TopBuild CorpBLD | 0%new |
| 9 | BrightSpring Health Services, Inc.BTSG | 0%new |
| 10 | AVRO - AVROBIO, Inc. | —— |
What share of all stock conversation is about PASG?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Attention | 0% 0 | 0% new | 0% 0 | 0% 0 |
Of the messages about PASG that take a side, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Bullish | — | — | — | 95.39% +5.51 | ||
| Bearish | — | — | — | 4.61% -5.51 |
Of the messages about PASG that carry a topic, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Announcements | — | — | — | 87.86% | ||
| Analysts | — | — | — | 4.35% | ||
| Controversies | — | — | — | 1.05% | ||
| Earnings | — | — | — | 0.15% | ||
| Macro | — | — | — | 0% | ||
| Technical Analysis | — | — | — | 6.6% |
Of the messages about PASG, what share comes from each group?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Regulars | — | 0% | 0% | 53.28% | ||
| Newcomers | — | 100% | 100% | 46.72% |